AGN
Price sensitive
Argenica Receives $3.97m R&D Tax Incentive Cash Rebate
Argenica Therapeutics Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in